Aurobindo Pharma arm receives VAI classification from USFDA for Telangana unit

Aurobindo Pharma’s subsidiary, Apitoria Pharma, received a ‘Voluntary Action Indicated’ (VAI) classification from the USFDA for its Telangana facility after a December 2025 inspection.

Leave a Reply

Your email address will not be published. Required fields are marked *